Sorrento Therapeutics Inc (SRNE) - Financial Analysis Review

Summary

Sorrento Therapeutics Inc (STI), formerly QuikByte Software, Inc., which develops novel treatments for cancer, inflammation and autoimmune diseases. It discovers small molecules, antibody drug conjugates, and antibodies for the treatment of cancer and its associated pain. Its pipeline products include mAbs, CAR-T, CAR.TNK and resiniferatoxin. STIs product Cynviloq is a novel nanoparticle formulation of paclitaxel, is used for the treatment of metastatic breast cancer, pancreatic cancer and non-small cell lung cancer. The company works in collaboration with biopharmaceutical companies and academic institutions to develop the novel immunotherapies. It also operates through its subsidiaries.

GlobalData's Sorrento Therapeutics Inc (SRNE) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

Sorrento Therapeutics Inc Key Recent Developments:

Sep 13,2016: Sorrento Appoints Miranda Toledano As Executive Vice President of Corporate Development, and President of LA Cell
Aug 15,2016: Dr. Jerome Zeldis, M.D., Ph.D., former Chief Medical Officer of Celgene, to Join Sorrento as Chief Medical Officer and President of Clinical Development
Aug 01,2016: Sorrento Therapeutics Announces the Appointment of Dr. Yue Alexander Wu to its Board of Directors
May 09,2016: Sorrento Therapeutics engaged advisors for exploring strategic alternatives
Apr 05,2016: Sorrento Appoints Kevin M. Herde As Chief Financial Officer


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major publi